• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国肝脏移植分配政策与结果:全面综述

Liver transplant allocation policies and outcomes in United States: A comprehensive review.

作者信息

Latt Nyan L, Niazi Mumtaz, Pyrsopoulos Nikolaos T

机构信息

Division of Gastroenterology and Hepatology, Department of Medicine, Rutgers-New Jersey Medical School, Newark, NJ 07101-1709, United States.

出版信息

World J Methodol. 2022 Jan 20;12(1):32-42. doi: 10.5662/wjm.v12.i1.32.

DOI:10.5662/wjm.v12.i1.32
PMID:35117980
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8790309/
Abstract

Liver transplant allocation policies in the United States has evolved over 3 decades. The donor liver organs are matched, allocated and procured by the Organ Procurement and Transplantation Network which is administered by the United Network of Organ Sharing (UNOS), a not-for-profit organization governed by the United States human health services. We reviewed the evolution of liver transplant allocation policies. Prior to 2002, UNOS used Child-Turcotte-Pugh score to list and stratify patients for liver transplantation (LT). After 2002, UNOS changed its allocation policy based on model for end-stage liver disease (MELD) score. The serum sodium is the independent indicator of mortality risk in patients with chronic liver disease. The priority assignment of MELD-sodium score resulted in LT and prevented mortality on waitlist. MELD-Sodium score was implemented for liver allocation policy in 2016. Prior to the current and most recent policy, livers from adult donors were matched first to the status 1A/1B patients located within the boundaries of the UNOS regions and donor-service areas (DSA). We reviewed the disadvantages of the DSA-based allocation policies and the advantages of the newest acuity circle allocation model. We then reviewed the standard and non-standard indications for MELD exceptions and the decision-making process of the National Review Liver Review Board. Finally, we reviewed the liver transplant waitlist, donation and survival outcomes in the United States.

摘要

美国的肝移植分配政策在过去30多年里不断演变。供体肝脏器官由器官获取与移植网络进行匹配、分配和获取,该网络由器官共享联合网络(UNOS)管理,UNOS是一个由美国人类健康服务部门管理的非营利组织。我们回顾了肝移植分配政策的演变。2002年之前,UNOS使用Child-Turcotte-Pugh评分对肝移植患者进行排队和分层。2002年之后,UNOS根据终末期肝病模型(MELD)评分改变了其分配政策。血清钠是慢性肝病患者死亡风险的独立指标。MELD-钠评分的优先分配导致了肝移植并降低了等待名单上的死亡率。MELD-钠评分于2016年应用于肝脏分配政策。在当前和最新政策之前,成年供体的肝脏首先与位于UNOS区域和供体服务区域(DSA)范围内的1A/1B级患者进行匹配。我们回顾了基于DSA的分配政策的缺点和最新的急性病区域分配模型的优点。然后,我们回顾了MELD例外情况的标准和非标准适应症以及国家肝脏评审委员会的决策过程。最后,我们回顾了美国的肝移植等待名单、捐赠情况和生存结果。

相似文献

1
Liver transplant allocation policies and outcomes in United States: A comprehensive review.美国肝脏移植分配政策与结果:全面综述
World J Methodol. 2022 Jan 20;12(1):32-42. doi: 10.5662/wjm.v12.i1.32.
2
Intraregional model for end-stage liver disease score variation in liver transplantation: Disparity in our own backyard.肝移植中区域性终末期肝病模型评分差异:自家后院的差异。
Liver Transpl. 2018 Apr;24(4):488-496. doi: 10.1002/lt.25021.
3
Use of rapid Model for End-Stage Liver Disease (MELD) increases for liver transplant registrant prioritization after MELD-Na and Share 35, an evaluation using data from the United Network for Organ Sharing.使用快速终末期肝病模型(MELD)增加了肝移植登记患者的优先排序,MELD-Na 和 Share 35 之后,这是使用美国器官共享网络数据进行的评估。
PLoS One. 2019 Oct 3;14(10):e0223053. doi: 10.1371/journal.pone.0223053. eCollection 2019.
4
Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.高 MELD 评分和严重肝性脑病的肝移植候选者的候补名单结局。
Dig Dis Sci. 2018 Jun;63(6):1647-1653. doi: 10.1007/s10620-018-5032-5. Epub 2018 Apr 2.
5
Development of the allocation system for deceased donor liver transplantation.deceased donor liver transplantation allocation system development
Clin Med Res. 2005 May;3(2):87-92. doi: 10.3121/cmr.3.2.87.
6
The sickest first? Disparities with model for end-stage liver disease-based organ allocation: one region's experience.先救治病情最重的患者?基于终末期肝病模型的器官分配存在的差异:一个地区的经验。
Liver Transpl. 2003 Nov;9(11):1211-5. doi: 10.1053/jlts.2003.50192.
7
Impact of the acuity circle model for liver allocation on multivisceral transplant candidates.肝脏分配的急症圈模型对多脏器移植候选者的影响。
Am J Transplant. 2022 Feb;22(2):464-473. doi: 10.1111/ajt.16803. Epub 2021 Aug 26.
8
MELD scores of liver transplant recipients according to size of waiting list: impact of organ allocation and patient outcomes.根据等待名单规模划分的肝移植受者的终末期肝病模型(MELD)评分:器官分配的影响及患者预后
JAMA. 2004 Apr 21;291(15):1871-4. doi: 10.1001/jama.291.15.1871.
9
Disparities in organ allocation and access to liver transplantation in the USA.美国器官分配和肝移植机会的差异。
Expert Rev Gastroenterol Hepatol. 2010 Apr;4(2):133-40. doi: 10.1586/egh.10.10.
10
Allocation of liver grafts worldwide - Is there a best system?全球肝脏移植的分配 - 是否存在最佳系统?
J Hepatol. 2019 Oct;71(4):707-718. doi: 10.1016/j.jhep.2019.05.025. Epub 2019 Jun 12.

引用本文的文献

1
The unwell patient with advanced chronic liver disease: when to use each score?患有晚期慢性肝病的不适患者:何时使用每种评分?
BMC Med. 2025 Jul 9;23(1):413. doi: 10.1186/s12916-025-04185-w.
2
Lesson learnt from 60 years of liver transplantation: Advancements, challenges, and future directions.从60年肝移植中汲取的经验教训:进展、挑战与未来方向。
World J Transplant. 2025 Mar 18;15(1):93253. doi: 10.5500/wjt.v15.i1.93253.
3
Inconsistent values and algorithmic fairness: a review of organ allocation priority systems in the United States.不一致的值和算法公平性:美国器官分配优先级系统综述。
BMC Med Ethics. 2024 Oct 17;25(1):115. doi: 10.1186/s12910-024-01116-x.
4
Pre-transplant Loco-Regional Therapy for Hepatocellular Carcinoma and Post-transplant Outcomes: A National Study.肝细胞癌移植前局部区域治疗与移植后结局:一项全国性研究。
Cureus. 2024 Aug 27;16(8):e67960. doi: 10.7759/cureus.67960. eCollection 2024 Aug.
5
Surgical Implications for Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma.非酒精性脂肪性肝炎相关肝细胞癌的手术意义
Cancers (Basel). 2024 Aug 6;16(16):2773. doi: 10.3390/cancers16162773.
6
The evolution of the liver transplant candidate.肝移植候选者的演变
Front Transplant. 2023 Jul 3;2:1178452. doi: 10.3389/frtra.2023.1178452. eCollection 2023.
7
BOMS: blockchain-enabled organ matching system.BOMS:基于区块链的器官匹配系统。
Sci Rep. 2024 Jul 11;14(1):16069. doi: 10.1038/s41598-024-66375-5.
8
Cold ischemia time in liver transplantation: An overview.肝移植中的冷缺血时间:综述。
World J Hepatol. 2024 Jun 27;16(6):883-890. doi: 10.4254/wjh.v16.i6.883.
9
Portal vein arterialization in 25 liver transplant recipients: A Latin American single-center experience.25例肝移植受者的门静脉动脉化:拉丁美洲单中心经验
World J Transplant. 2024 Jun 18;14(2):92528. doi: 10.5500/wjt.v14.i2.92528.
10
Ethics in hepatology: A professional and very personal journey.肝病学中的伦理:一段专业且极具个人色彩的历程。
Clin Liver Dis (Hoboken). 2024 Jun 14;23(1):e0231. doi: 10.1097/CLD.0000000000000231. eCollection 2024 Jan-Jun.

本文引用的文献

1
A 6-Month Report on the Impact of the Organ Procurement and Transplantation Network/United Network for Organ Sharing Acuity Circles Policy Change.器官获取与移植网络/器官共享联合网络急性病分级政策变更影响的6个月报告
Liver Transpl. 2021 May;27(5):756-759. doi: 10.1002/lt.25972. Epub 2021 Feb 15.
2
OPTN/SRTR 2017 Annual Data Report: Liver.OPTN/SRTR 2017 年度数据报告:肝脏。
Am J Transplant. 2019 Feb;19 Suppl 2:184-283. doi: 10.1111/ajt.15276.
3
MELD Exceptions and Rates of Waiting List Outcomes.MELD 例外和候补名单结果的比例。
Am J Transplant. 2011 Nov;11(11):2362-71. doi: 10.1111/j.1600-6143.2011.03735.x. Epub 2011 Sep 15.
4
Hyponatremia and mortality among patients on the liver-transplant waiting list.肝移植等待名单上患者的低钠血症与死亡率
N Engl J Med. 2008 Sep 4;359(10):1018-26. doi: 10.1056/NEJMoa0801209.
5
Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula.终末期肝病模型(MELD)例外准则:MELD例外研究小组及会议(MESSAGE)关于批准那些患有标准MELD公式未考虑疾病而需要肝移植患者的结果与建议。
Liver Transpl. 2006 Dec;12(12 Suppl 3):S128-36. doi: 10.1002/lt.20979.
6
Serum sodium predicts mortality in patients listed for liver transplantation.血清钠可预测列入肝移植名单患者的死亡率。
Hepatology. 2005 Jan;41(1):32-9. doi: 10.1002/hep.20517.
7
Model for end-stage liver disease (MELD) and allocation of donor livers.终末期肝病模型(MELD)与供肝分配
Gastroenterology. 2003 Jan;124(1):91-6. doi: 10.1053/gast.2003.50016.
8
Model for end-stage liver disease and Child-Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients.终末期肝病模型和Child-Turcotte-Pugh评分作为器官共享联合网络2A级患者移植前疾病严重程度、移植后结局及资源利用的预测指标。
Liver Transpl. 2002 Mar;8(3):278-84. doi: 10.1053/jlts.2002.31340.
9
A model to predict survival in patients with end-stage liver disease.一种预测终末期肝病患者生存率的模型。
Hepatology. 2001 Feb;33(2):464-70. doi: 10.1053/jhep.2001.22172.
10
A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.预测经颈静脉肝内门体分流术患者生存预后不良的模型。
Hepatology. 2000 Apr;31(4):864-71. doi: 10.1053/he.2000.5852.